Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study

被引：0
|
作者：
Kawase, Kazuhide [1 ]
Vittitow, Jason L. [2 ]
Yamamoto, Tetsuya [1 ]
Araie, Makoto [3 ]
机构：
[1] Gifu Univ Hosp, Gifu, Japan
[2] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA
[3] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3037
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
    Kawase, Kazuhide
    Vittitow, Jason L.
    Weinreb, Robert N.
    Araie, Makoto
    ADVANCES IN THERAPY, 2016, 33 (09) : 1612 - 1627
  • [2] Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
    Kazuhide Kawase
    Jason L. Vittitow
    Robert N. Weinreb
    Makoto Araie
    Advances in Therapy, 2016, 33 : 1612 - 1627
  • [3] Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies
    Vittitow, Jason L.
    Liebmann, Jeffrey M.
    Kaufman, Paul L.
    Medeiros, Felipe A.
    Martin, Keith R.
    Weinreb, Robert N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study
    Peace, James H.
    Medeiros, Felipe A.
    Martin, Keith R.
    Vittitow, Jason L.
    Weinreb, Robert N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
    Weinreb, Robert N.
    Liebmann, Jeffrey M.
    Martin, Keith R.
    Kaufman, Paul L.
    Vittitow, Jason L.
    JOURNAL OF GLAUCOMA, 2018, 27 (01) : 7 - 15
  • [6] Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
    Hoy, Sheridan M.
    DRUGS, 2018, 78 (07) : 773 - 780
  • [7] Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
    Sheridan M. Hoy
    Drugs, 2018, 78 : 773 - 780
  • [8] Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension The APOLLO Study
    Weinreb, Robert N.
    Sforzolini, Baldo Scassellati
    Vittitow, Jason
    Liebmann, Jeffrey
    OPHTHALMOLOGY, 2016, 123 (05) : 965 - 973
  • [9] Latanoprostene Bunod 0.024% in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Meta-Analysis
    Lo, Tzu-Chen
    Chen, Yu-Yen
    Hung, Man-Chen
    Chou, Pesus
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [10] Response symmetry of the eyes to latanoprostene bunod (LBN) 0.024% in open-angle glaucoma and ocular hypertension
    Doustkhahvajari, Mahta
    Najafi, Ahmad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
12345